Back to today’s briefing

Story perspectives

16-Year-Old Beats Leukemia with Revolutionary Gene Editing

4/25/2025

22 2

Summary

Story summary

Alyssa Tapley, just 16, triumphed over T-cell leukemia thanks to an innovative gene-editing therapy known as base editing, pioneered by Harvard's David Liu. This revolutionary approach, which fixes genetic mutations, has sparked 18 clinical trials. Liu passionately advocates for the significance of foundational science while voicing worries about the hurdles young researchers encounter today.

1 of 1

Story summary

Alyssa Tapley, just 16, triumphed over T-cell leukemia thanks to an innovative gene-editing therapy known as base editing, pioneered by Harvard's David Liu. This revolutionary approach, which fixes genetic mutations, has sparked 18 clinical trials. Liu passionately advocates for the significance of foundational science while voicing worries about the hurdles young researchers encounter today.